Telemedicine Across the Cancer Care Continuum: Evidence and Opportunities for Clinical Care, Research, and Policy.

Nekhlyudov, Larissa; Fleisher, Lee A; Jacobsen, Paul B

Nekhlyudov, Larissa; Fleisher, Lee A; Jacobsen, Paul B.

Nekhlyudov L; From the Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Fleisher LA; Center for Clinical Standards & Quality, Centers for Medicare & Medicaid Services, Washington, DC.
Jacobsen PB; Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.

Cancer J ; 28(2): 121-124, 2022.

Article in English | MEDLINE | ID: covidwho-1764715

ABSTRACT

ABSTRACT

ABSTRACT In this commentary, we provide an overview about the surge of telemedicine services during the COVID-19 pandemic, describe the cancer care continuum and existing evidence regarding the use of telemedicine across the continuum, and offer our perspective on existing opportunities to advance the use of telemedicine in clinical care, research, and policy. While research implications are relevant to an international audience, our focus pertains specifically to health care delivery and policy in the United States.

Subject(s)

COVID-19; Neoplasms; Telemedicine; COVID-19/epidemiology; Continuity of Patient Care; Humans; Neoplasms/therapy; Pandemics; Policy; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Cancer J Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: Ppo.0000000000000585

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google